0001596494-20-000001.txt : 20200401 0001596494-20-000001.hdr.sgml : 20200401 20200401153237 ACCESSION NUMBER: 0001596494-20-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200401 DATE AS OF CHANGE: 20200401 EFFECTIVENESS DATE: 20200401 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ralexar Therapeutics, Inc. CENTRAL INDEX KEY: 0001596494 IRS NUMBER: 463970052 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-329633 FILM NUMBER: 20765223 BUSINESS ADDRESS: STREET 1: 640 LEE ROAD STREET 2: SUITE 118 CITY: WAYNE STATE: PA ZIP: 19087 BUSINESS PHONE: 484-318-2988 MAIL ADDRESS: STREET 1: 640 LEE ROAD STREET 2: SUITE 118 CITY: WAYNE STATE: PA ZIP: 19087 FORMER COMPANY: FORMER CONFORMED NAME: Alexar Therapeutics, Inc. DATE OF NAME CHANGE: 20140110 D/A 1 primary_doc.xml X0708 D/A LIVE 0001596494 Ralexar Therapeutics, Inc. 662 Encinitas Blvd. Suite 250 Encinitas CA CALIFORNIA 92024 484-318-2988 DELAWARE Alexar Therapeutics, Inc. Corporation true David Pfeiffer c/o Ralexar Therapeutics, Inc. 640 Lee Road, Suite 118 Wayne PA PENNSYLVANIA 19087 Executive Officer Director Stephen Tullman c/o Ralexar Therapeutics, Inc. 640 Lee Road, Suite 118 Wayne PA PENNSYLVANIA 19087 Executive Officer Director Neal Walker c/o Ralexar Therapeutics, Inc. 640 Lee Road, Suite 118 Wayne PA PENNSYLVANIA 19087 Director Somasundaram Subramaniam c/o New Science Ventures LLC 610 Fifth Avenue, 3rd Floor New York NY NEW YORK 10022 Director Jason Hong c/o Third Point LLC 390 Park Avenue, 19th Floor New York NY NEW YORK 10022 Director Pharmaceuticals Decline to Disclose 06b true 0001596494-19-000002 2018-12-20 true true true false 0 6000000 4277926 1722074 false 11 0 0 300000 true false Ralexar Therapeutics, Inc. /s/ David Pfeiffer David Pfeiffer Chief Executive Officer 2020-03-25